PROS1 and chronic kidney disease: Kaesler et al. [30] demonstrated in a preclinical study that the activity of γ-glutamyl carboxylase, the enzyme that catalyzes the posttranslational γ-carboxylation of vitamin K-dependent proteins such as MGP, was reduced in CKD.